However, a potential biological role for CNP (and its cognate receptors, NPR-B and NPR-C) in counteracting the development of chronic liver diseases and their complications (e.g. portal hypertension), and as a potential therapy for such disorders, remains to be established. This evidence concerns the gene NPR2 and portal hypertension.